XML 21 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Operating Activities of Continuing Operations      
Net earnings $ 570,267 $ 811,665 $ 508,892
Adjustments to reconcile net earnings to cash from operating activities:      
(Loss) earnings from discontinued operations, net 20,878 (65,002) (6,764)
Depreciation and amortization 282,580 283,278 249,672
Stock-based compensation 23,698 24,073 18,650
Gain on sale of business 0 (203,135) (96,598)
Provision for losses on accounts receivable (net of recoveries) 3,875 10,341 7,700
Deferred income taxes (35,448) (160,395) (43,258)
Employee benefit plan expense 11,912 12,191 25,364
Contributions to employee benefit plans (25,933) (18,588) (23,042)
Other, net (6,762) (4,216) (31,965)
Cash effect of changes assets and liabilities (excluding effects of acquisitions, dispositions and foreign exchange):      
Accounts receivable (87,573) (43,450) (74,049)
Inventories (85,052) 605 (3,287)
Prepaid expenses and other assets (7,453) (5,232) (415)
Accounts payable 106,561 94,052 70,836
Accrued compensation and employee benefits (7,037) 23,319 (10,429)
Accrued expenses and other liabilities (5,026) (36,024) 49,960
Accrued taxes 29,706 15,927 93,329
Net cash provided by operating activities of continuing operations 789,193 739,409 734,596
Investing Activities of Continuing Operations      
Additions to property, plant and equipment (170,994) (170,068) (139,578)
Payments to Acquire Businesses, Net of Cash Acquired 68,557 27,188 1,561,737
Proceeds from the sale of property, plant and equipment 5,908 11,774 15,223
Proceeds from the sale of businesses 3,937 372,666 206,407
Other (15,774) 21,151 (1,057)
Net cash provided by (used in) investing activities of continuing operations (245,480) 208,335 (1,480,742)
Financing Activities of Continuing Operations      
Cash received from Apergy, net of cash distributed 689,643 0 0
Proceeds from long-term debt 0 0 656,399
Proceeds from exercise of share-based awards, including tax benefits 0 0 8,431
Change in commercial paper and notes payable, net (10,722) (182,596) 254,834
Repayment of long-term debt (350,000) 0 (1,889)
Dividends to stockholders (283,570) (283,959) (267,739)
Purchase of common stock (894,977) (105,023) 0
Payments for employee tax obligations upon exercise of share-based awards (46,254) (18,443) (15,700)
Other (1,958) (2,912) 0
Net cash provided by (used in) financing activities of continuing operations (897,838) (592,933) 634,336
Cash Flows from Discontinued Operations      
Net cash provided by operating activities of discontinued operations 9,442 96,225 128,346
Net cash used in investing activities of discontinued operations (23,705) (46,484) (24,231)
Net cash used in financing activities of discontinued operations 0 (1,208) (600)
Net cash (used in) provided by discontinued operations (14,263) 48,533 103,515
Effect of exchange rate changes on cash and cash equivalents 10,645 1,474 (4,744)
Net decrease in cash and cash equivalents (357,743) 404,818 (13,039)
Cash and cash equivalents at beginning of period 753,964 349,146 362,185
Cash and cash equivalents at end of period 396,221 753,964 349,146
Supplemental information - cash paid during the year for [Abstract]      
Income taxes 135,427 337,987 170,394
Interest $ 131,823 $ 140,863 $ 131,184